Alnylam Pharmaceuticals
ALNY
#578
Rank
S$46.20 B
Marketcap
$359.93
Share price
1.16%
Change (1 day)
46.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividends for this company